Your results for

Filter by

Filter by
Results

Filter by

Content type
Key content topics
Key audience
Top cancer treatments

ASTRO Radiation Therapy Summary of the ASCO Guideline on Management of Stage III Non-Small Cell Lung Cancer.

16/06/2023
/ Publications
/
Dosimetry

Based on the ‘Management of Stage III Non-Small-Cell Lung Cancer: ASCO Guideline’, this summary document makes recommendations directly related to RT for the...

Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy.

16/05/2021
/ Publications
/
Dosimetry
Reirradiation
Toxicity

A review article compared the clinical evidence including the parameters of the dose distribution in organs at risk, such as the heart, blood vessels, and lungs...

Proton Therapy for Partial Breast Irradiation: Rationale and Considerations.

16/04/2021
/ Publications
/
Reirradiation

A review specifically for PBT partial breast irradiation. This review found that tumor control with PT is excellent, and the toxicities associated with PT PBI...

A retrospective study of adjuvant proton radiotherapy for breast cancer after lumpectomy: a comparison of conventional-dose and hypofractionated dose.

16/03/2023
/ Publications
/
Dosimetry
Hypofractionation
Toxicity

Fifty patients were treated with PT using two different regimens following lumpectomy. 14 patients received IMPT to a total dose of 50 Gy in 25 fractions...

The Potential of Proton Therapy for Locally Advanced Breast Cancer: Clinical and Technical Considerations.

16/02/2023
/ Publications
/
Toxicity

This review presented the rationale of using protons in the setting of locally advanced breast cancer, which is to mitigate treatment related toxicity...

Postmastectomy Intensity Modulated Proton Therapy: 5-Year Oncologic and Patient-Reported Outcomes.

16/11/2023
/ Publications
/
IMPT

127 patients received unilateral conventionally fractionated postmastectomy IMPT. Median follow-up was 4.1 years. Five-year LRC was 98.4% and OS was 87.9%...

Radiation-induced skin and heart toxicity in patients with breast cancer treated with adjuvant proton radiotherapy: a comparison with photon radiotherapy.

16/10/2023
/ Publications
/
Dosimetry
Toxicity

The active and inactive (pro-BNP and NT-proBNP) forms of BNP are classically used as biomarkers for diagnosing and monitoring acute and chronic heart failure...

Image-Guided Proton Therapy for Elderly Patients with Hepatocellular Carcinoma: High Local Control and Quality of Life Preservation.

16/12/2021
/ Publications
/
Quality of life

This study reported the efficacy and safety of image-guided proton therapy (IGPT) for elderly (≥80 years old) hepatocellular carcinoma (HCC) patients. Seventy...

Long-term clinical outcomes of patients receiving proton beam therapy for caudate lobe hepatocellular carcinoma.

16/07/2021
/ Publications
/
Clinical Trial

Thirty patients with caudate lobe HCC were treated to a total doses of 55 to 77 (median 72.6) GyRBE. The median follow-up period was 37.5 months. The OS rates...

A phase II trial of hypofractionated high-dose proton beam therapy for unresectable liver metastases.

16/11/2022
/ Publications
/
Dosimetry
Toxicity

This study analyzed 46 patients with 49 liver metastases treated by PBT to a total dose of 60 GyRBE in 5 fractions (BED 132 GyE) or 70 GyRBE in 10 (BED 119 GyE)...